Evidence map›Paper›PMID 37274318›Full record

ArticleFrontiers in cellular and infection microbiology2023

Complete genome analysis of

Maryoris Elisa Soto Lopez, Marco Tulio Pardini Gontijo, Rodrigo Rezende Cardoso, Laís Silva Batalha, Monique Renon Eller, Denise Mara Soares Bazzolli, Pedro Marcus Pereira Vidigal, Regina Célia Santos Mendonça

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Safety Properties ofFoods (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Maryoris Elisa Soto LopezDepartamento de Tecnologia de Alimentos, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Marco Tulio Pardini GontijoDepartamento de Tecnologia de Alimentos, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Rodrigo Rezende CardosoDepartamento de Tecnologia de Alimentos, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Laís Silva BatalhaDepartamento de Tecnologia de Alimentos, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Monique Renon EllerDepartamento de Tecnologia de Alimentos, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Denise Mara Soares BazzolliDepartamento de Microbiologia, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Pedro Marcus Pereira VidigalNúcleo de Análise de Biomoléculas, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Regina Célia Santos MendonçaDepartamento de Tecnologia de Alimentos, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.
Universidade Federal de Viçosa · BRDuke University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Bacteriophages infecting human pathogens have been considered potential biocontrol agents, and studying their genetic content is essential to their safe use in the food industry. Methods: Results: Here, we characterize its genome and compare it to other Conclusion: The results in this paper, combined with other previously published findings, indicate that

Indexed as

BacteriophagesEscherichia coli O157Base SequenceGenomeGenomicsHumansbiocontrolEnterohemorrhagic Escherichia colipan-genometaxonomywhole genome sequencing (WGS)

Identifiers

PMID37274318
PMCPMC10236363
OpenAlexW4376890981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.